A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

Clinical trial NCT01519778 · COMPLETED

Trial details

NCT number: NCT01519778
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Cutaneous Abscess Cellulitis Erysipelas

Start date: 2012-02-15
Primary completion: 2012-08-27
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.